Back to discover
Drug

Leucine

In clinical development
Emerging researchLate-stage development
Also known as (2S)-2-Amino-4-methylpentanoic acid, (2S)-alpha-2-Amino-4-methylvaleric acid, (2S)-alpha-Leucine, (S)-(+)-Leucine+45 more

(2S)-2-Amino-4-methylpentanoic acid, (2S)-alpha-2-Amino-4-methylvaleric acid, (2S)-alpha-Leucine, (S)-(+)-Leucine, (S)-Leucine, 2-Amino-4-methylvaleric acid, Aminosyn 10%, Sulfite-Free, Aminosyn 3.5 % M, Sulfite Free, Aminosyn 8.5 % with Electrolytes, Sulfite-Free, Aminosyn 8.5%, Sulfite-Free, Aminosyn II 10 %, Aminosyn II 15%, Aminosyn II 8.5 % with Electrolytes, Sulfite-Free, Aminosyn II 8.5 %, Sulfite-Free, Aminosyn-HBC 7 %, Sulfite-Free, Aminosyn-PF 10 %, Sulfite-Free, Aminosyn-PF 7%, Branchamin, Clinisol 15, Freamine III 10, Hepatamine 8, Hepatasol, L, L-Leucin, L-Leucine, L-Leuzin, Leu, Nephramine, Plenamine, PremaSol, ProSol, ProcalAmine 3, Travasol 10, Travasol 10%, Trophamine, Trophamine 10 %, Trophamine 6 %, Clinimix 4.25/10, Clinimix 4.25/25, Clinimix 4.25/5, Clinimix 5/15, Clinimix 5/20, Clinimix 5/25, Clinimix E 2.75/5, Clinimix E 4.25/10, Clinimix E 4.25/5, Clinimix E 5/15, Clinimix E 5/20, Clinimix E 5/25.

2
Research papers
2
Active clinical trials
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Leucine as a Probe of Kynurenine-Induced Glutamate and Neural Circuit Dysfunction in Midlife Depression

Clinical trial2025-04-24Results expected Q2 2028 · ClinicalTrials.gov

An Experimental Treatment Approach for Inflammation-Induced Depression

Clinical trial2021-07-31Terminated · ClinicalTrials.gov

The Effect of Lidocaine to Prevent the Development of Chronic Post-Surgical Pain

Clinical trial2019-11-27Results posted · ClinicalTrials.gov

Collaborative Research Group for Necrotizing Enterocolitis

Clinical trial2018-04-04Results posted · ClinicalTrials.gov

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Leucine
Aliases & brands
(2S)-2-Amino-4-methylpentanoic acid(2S)-alpha-2-Amino-4-methylvaleric acid(2S)-alpha-Leucine(S)-(+)-Leucine(S)-Leucine2-Amino-4-methylvaleric acidAminosyn 10%, Sulfite-FreeAminosyn 3.5 % M, Sulfite FreeAminosyn 8.5 % with Electrolytes, Sulfite-FreeAminosyn 8.5%, Sulfite-FreeAminosyn II 10 %Aminosyn II 15%Aminosyn II 8.5 % with Electrolytes, Sulfite-FreeAminosyn II 8.5 %, Sulfite-FreeAminosyn-HBC 7 %, Sulfite-FreeAminosyn-PF 10 %, Sulfite-FreeAminosyn-PF 7%BranchaminClinisol 15Freamine III 10Hepatamine 8HepatasolLL-LeucinL-LeucineL-LeuzinLeuNephraminePlenaminePremaSolProSolProcalAmine 3Travasol 10Travasol 10%TrophamineTrophamine 10 %Trophamine 6 %Clinimix 4.25/10Clinimix 4.25/25Clinimix 4.25/5Clinimix 5/15Clinimix 5/20Clinimix 5/25Clinimix E 2.75/5Clinimix E 4.25/10Clinimix E 4.25/5Clinimix E 5/15Clinimix E 5/20Clinimix E 5/25
RxNorm CUI
6308
ChEMBL ID
CHEMBL291962
UNII
GMW67QNF9C

Clinical trials

16 trials

The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.

Development programme
CLINICALTRIALS.GOV · LIVE REGISTRY
16
registered trials across all phases
LATEST COMPLETION 2023
2
Active studies
2
Recruiting
11
Late-stage (III+)
7
Completed
7
Discontinued
PHASE DISTRIBUTIONn = 16
Early Phase 11Phase 1 / 21Phase 23Phase 42Phase N / A9

Late-stage studies

Phase III+ trials still open or recently active — where late-stage evidence is being generated.

Recent completions

Trials that read out recently, adding to the completed evidence base.

Research activity

2 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Publications over time
20052024
Major research themes5
Cytokine Release Syndrome1Genome, Archaeal1Genome, Bacterial1Interleukin-41Software1
Journals, researchers & institutions
Top journals
  • eLife1
  • Nucleic acids research1
Leading researchers
  • Begley T1
  • Butler RM1
  • Chen D1
  • Choudhuri JV1
  • Chuang HY1
  • Cohoon M1
  • de Crécy-Lagard V1
  • Diaz N1
Leading institutions
free-text, unnormalised
  • Key Laboratory of Animal Disease Resistance Nutrition of China Ministry of Education1

Related drugs

1 matches

Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).

Frequently co-studied with Leucine in the research literature.

1 shared paper
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
  • Europe PMC — research literature
  • ClinicalTrials.gov — clinical trials